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A shift in the Bax/Bcl-2 balance may activate caspase-3 and Chronic glomerulonephritis remains a leading cause
modulate apoptosis in experimental glomerulonephritis. of end-stage renal disease, with initial inflammatory
Background. Although apoptosis has been linked to the re- changes followed by glomerulosclerosis, tubular atrophynal cell deletion and ensuing renal fibrosis, its regulating mecha-
and interstitial fibrosis [1]. Over the last decade, a greaternisms remain obscure. Of the known regulators of apoptosis,
understanding of the mediators and mechanisms in-the best characterized is the Bax to Bcl-2 ratio. However, its
importance in controlling apoptosis in glomerulonephritis is volved in the progression of glomerulonephritis and re-
unclear. Here, using the nephrotoxic nephritis (NTN) model, nal scarring has been attained, although these are far
we evaluated Bax/Bcl-2 in relation to changes in the apoptosis
from complete. One particular area of interest is theco-ordination enzyme, caspase-3.
role of apoptosis (programmed cell death) both in theMethods. Kidneys were harvested at days 7, 15, 30 and 45
post-injection of anti-glomerular basement membrane anti- successful resolution [2] and progression [3] of glomeru-
body into Wistar Kyoto rats. These were analyzed for apoptosis lonephritis.
(in situ end labeling of fragmented DNA, light and electron Apoptosis allows the clearance of infiltrating inflam-microscopy), Bax/Bcl-2 protein (Western blotting), mRNA
matory cells, which is beneficial in the resolution of glo-(Northern blotting) and distribution (immunohistochemistry),
merulonephritis [2]. Conversely, the inappropriate acti-as well as caspase-3 activity (substrate cleavage assay), inflam-
mation (ED1 staining), proliferation (proliferating cell nuclear vation of apoptosis may contribute to the deletion of
antigen staining) and fibrosis (Masson’s Trichrome staining). glomerular and tubular cells, thus leading to glomerulo-
Results. Bax mRNA was significantly increased while that sclerosis and tubular atrophy [3–8]. Our work and thatof Bcl-2 was decreased throughout the time course (265%
of others has highlighted the importance of apoptosis inand 62% by day 45). Increased Bax and decreased Bcl-2
the development of glomerulosclerosis and tubular atro-protein were noted, significantly so on day 7 (177% and
21%) and day 45 (363% and 17%). Bax protein was phy in the kidneys of rats with immune- [3, 4] and non-
observed in dilated and atrophic tubules, sclerotic glomeruli immune- [5–8] mediated renal disease. In these models
and inflamed interstitium, while Bcl-2 was only visible in
cellular apoptosis outweighed proliferation, thus favor-atrophic tubules. The ratios of Bax to Bcl-2 mRNA and protein
ing cell deletion and the progression of tissue fibrosis. Wewere significantly increased at all time points. These correlated
(P  0.05) with up-regulated caspase-3 activity (r  0.742 and also detected a strong association between renal apoptosis
0.531), apoptosis (r 0.712 and 0.540), proliferation (r 0.611, and fibrosis, and suggest that the loss of renal cells through
mRNA only), inflammation (ED1, r  0.474 and 0.419) and apoptosis may be a major element of renal scarring [4, 6].
fibrosis (r  0.474 and 0.729).
In the rat chronic nephrotoxic nephritis (NTN) model,Conclusions. Our findings suggest that the changes in the
the early peak of glomerular apoptosis is likely to resultratio of Bax to Bcl-2 may contribute to the caspase-3 activation
and the modulation of renal apoptosis associated with renal from the appropriate clearance of inflammatory cells re-
inflammation, tubular atrophy and renal fibrosis in experimen- cruited into the glomeruli during the initial immune re-
tal glomerulonephritis. sponse [4]. The later peak of tubulointerstitial apoptosis
coincides with the severe tubular atrophy and interstitial
injury that characterize the late stages of this model [4].Key words: cell death, proliferation, inflammation, glomerulonephritis,
renal scarring, tubular atrophy, chronic renal failure. Moreover, we have found a strong association between
the up-regulation of caspase-3 (a key execution enzymeReceived for publication July 23, 2001
in apoptosis) and the occurrence of apoptosis in this modeland in revised form April 11, 2002
Accepted for publication May 24, 2002 [4]. Parallel changes in inflammation and scarring/fibrosis
were noted that correlated with both apoptosis and cas- 2002 by the International Society of Nephrology
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pase-3 levels. In the subtotal nephrectomy (SNx) model [4, 15]. Rats were sacrificed in groups (N  4 to 7) at
days 7, 15, 30 and 45 after serum injection. Removedof chronic renal scarring, an increased ratio of pro-apopto-
sis Bax (Bcl-2 associated protein X) to anti-apoptosis Bcl-2 kidney tissues were snap frozen and stored in liquid
nitrogen for mRNA and protein analysis. Kidneys were(B cell lymphoma/leukemia 2) has been found [8]. This
was associated with the occurrence of apoptosis and the fixed in 10% (wt/vol) neutral buffered formalin for histo-
logical and immunohistochemical examination and inprogression of renal fibrosis. It remains to be determined if
the Bax/Bcl-2 system also is involved in immune-mediated 2.5% (vol/vol) glutaraldehyde solution in phosphate buf-
fered saline (PBS) buffer (pH 7.4) for electron micros-glomerulonephritis and the subsequent renal scarring, and
importantly, if this relates to the activation of caspase-3. copy. Serum creatinine (SCr) concentration (standard auto-
analyzer techniques) and 24-hour urinary protein (Uprot)So far, 15 Bcl-2 related proteins have been identified
in the Bcl-2 family, and they fall into two categories, anti- excretion (Biuret method) were determined in each group
at all time points.and pro-apoptosis [9, 10]. Bcl-2 homodimers have been
shown to inhibit apoptosis and prolong cell survival in
Estimation of renal scarringvarious settings [10, 11]. Bax homodimers, sharing se-
quence homology with Bcl-2, act as a binding protein The severity of renal scarring was assessed using two
independent scoring systems. Initially scarring was scoredof Bcl-2 and favor cell death [12]. Heterodimerization
between Bax and Bcl-2 may abolish the function of either by two authors blinded to the experimental code on Mas-
son’s Trichrome (MT) stained sections at 200 magnifi-protein [12]. In many systems members of the Bcl-2 family
modulate apoptosis, with the ratio of Bax to Bcl-2 serving cation according to a published arbitrary scale [16–19].
Briefly, normal glomerulus scored 0; mild glomeruloscle-as a rheostat to determine the susceptibility of cells to
apoptosis [10, 11]. rosis (GS) affecting up to 25% of the glomerular tuft
scored 1; moderate GS affecting between 25 and 50%Caspases, especially caspase-3, are known to act down-
stream of Bax/Bcl-2 control and play a key role in the of the tuft scored 2; and severe GS affecting over 50%
of the tuft scored 3. Similarly, normal tubulointerstitiumexecution of apoptosis [13]. Recent evidence suggests
that Bcl-2 also acts as a downstream death substrate of with approximately 1000 tubular cells per 200 magnifi-
cation field scored 0; mild tubular atrophy (TA), withcaspases and thus, that the caspase enzymes may be
able to inactivate the Bcl-2 anti-apoptotic function and approximately 800 tubular cells per field and interstitial
edema or fibrosis (IF) affecting up to 25% of the fieldfurther enhance cell death, even when apoptosis is trig-
gered via a non-Bax/Bcl-2 dependent pathway. Although scored 1; moderate TA with approximately 600 tubular
cells per field and IF affecting 25% to 50% of the fieldthere is a feedback loop between Bcl-2 and caspase,
Bcl-2 cannot always inhibit apoptosis, implying a subset scored 2; and severe TA with approximately 400 tubular
cells and IF affecting more than 50% of the field scoredof caspase activation that is likely to run through the
death receptor pathway [14]. 3. Data were collected from a series of adjacent fields
extending perpendicularly from the cortex toward theWith this information in mind, we investigated the
expression of Bax and Bcl-2 at the mRNA and protein outer medulla [20]. Three such randomly selected linear
series of a minimum of 12 fields were measured in thelevels in the rat kidneys with NTN. We describe the rela-
tionship between the ratio of Bax/Bcl-2, caspase-3 activity cortex or such number of fields until 30 glomeruli had
been counted per section.and apoptosis as well as renal proliferation, inflamma-
tion, tubular atrophy and subsequent renal fibrosis. To confirm the arbitrary score of tubulointerstitial in-
jury, a computer-aided point counting system was em-
ployed on the same Masson’s Trichrome stained sections
METHODS
applying an identical field selection protocol to that the
Nephrotoxic serum nephritis arbitrary method. At least 12 200 magnification fields
were acquired using a JVC 3 chip video camera and aMale Wistar Kyoto rats weighing 200 to 300 g were
housed at constant temperature (20C) and humidity Scion CG-7 frame grabber (Scion Corp., Fredrick, MD,
USA). Images were imported into NIH-Image where a(45%) on a 12-hour light/dark cycle, fed ad libitum on
standard laboratory rat chow (Lab Sure Ltd, March, 30-point grid was overlaid onto each microscope field.
Points falling on areas of dilated or atrophied tubulesCambridge, UK) and had free access to tap water. All
experiments were carried out according to the rules and and fibrotic interstitium were manually selected on each
field and the percentage of positive points from all fieldsregulations laid down by the Home Office (Animal Sci-
entific Procedure Act 1986, UK). NTN was induced in calculated using NIH-Image’s internal macro facility.
28 rats by a single intravenous injection of 0.5 mL rabbit
Northern blot analysis of Bax and Bcl-2 mRNAanti-rat glomerular basement membrane serum with the
same amount of normal rabbit serum (Vector Labora- Total RNA was extracted using TRIzol reagent (Life
Technologies BRL, Paisley, UK) and quantified by scan-tories, Peterborough, UK) given to 16 rats as control
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ning spectrophotometer. Twenty-five micrograms of to- dilution (Santa Cruz, USA) at room temperature for
two hours. Primary Bax or Bcl-2 antibody binding wastal RNA was electrophoresed on a 1.0% (wt/vol) agarose
3[N-morpholino]propane sulfonic acid (MOPS)/formal- revealed using an anti-rabbit-HRP (Dako, Glostrup,
Denmark) or an anti-mouse-HRP antibody (Santa Cruzdehyde gel and viewed under ultraviolet (UV) light to
verify loading and the presence of intact ribosomal bands. Biochemicals) at 1:2000 or 1:1000 dilution for one hour
and the ECL detection system. Developed films wereRNA was then transferred to a nylon membrane (Hy-
bond-N; Amersham Pharmacia Biotech Ltd., Bucking- quantitatively analyzed by volume densitometry using a
Bio-Rad GS-690 scanning densitometer and Molecularhamshire, UK) and fixed by UV crosslinking (UV cross-
linker, Amersham Pharmacia Biotech Ltd.) [8, 21, 22]. Analyst version 4 software (Bio-Rad Laboratories Ltd.).
The Bax to Bcl-2 ratio was determined in the same man-The Bax and Bcl-2 cDNA probes were amplified by the
polymerase chain reaction (PCR) [8] based on previously ner as that for mRNA.
published rat cDNA sequences: Bax primers: 5-sense
Immunostaining for Bax, Bcl-2, PCNA and ED1CACCAGCTCTGAACAGATC, 3-antisense CTTCTT
CCAGATGGTGAGC [23]; Bcl-2 primers: 5-sense CCT Localization of Bax, Bcl-2, proliferating cell nuclear
antigen (PCNA) and ED1 (a specific monocyte/macro-GAGAGCAACCGAACG, 3-antisense CCTGAGAG
CAACCGAACG [24]. The cDNA probes were random phage marker) was detected in 10% neutral-buffered
formalin fixed, paraffin-embedded 4-m sections by im-primed with 32P labeled dCTP (NEN, Boston, MA, USA)
using the Prime-a-Gene Labeling System (Promega, munohistochemistry using a standard avidin-biotin per-
oxidase complex technique [17]. After deparaffinizationSouthampton, UK). Prehybridization and hybridization
were performed using the Church buffer system [500 and hydration, the sections were heated at 95C in pH
7.0 10 mmol/L citrate acid buffer for Bax or Bcl-2, ormmol/L sodium phosphate and 7% sodium dodecyl sul-
fate (SDS)] at 65C [4, 25]. The filter was washed three pre-treated with 0.25% (wt/vol) trypsin for ED1 [4, 8].
The activity of endogenous peroxidase was quenched bytimes in Church wash buffer (40 mmol/L sodium phos-
phate and 1% SDS) at 65C for 20 minutes and then 3% (vol/vol) H2O2 in methanol. The sections were then
incubated with the primary antibody overnight at 4C inexposed to Kodak Biomax MS film for 24 hours (East-
man Kodak, Rochester, NY, USA). Autoradiographs a humid atmosphere. Polyclonal rabbit anti-mouse Bax
(P-19; Santa Cruz Biochemicals), monoclonal mousewere quantitatively analyzed by scanning volume density
using a Bio-Rad GS-690 densitometer and Molecular anti-rat Bcl-2 (to confirm Bcl-2 staining; Santa Cruz Bio-
chemicals), monoclonal mouse anti-human PCNA (cloneAnalyst version 4 analysis software (Bio-Rad Labora-
tories Ltd., Hertz, UK). Transcript size was determined PC10; Dako) or monoclonal mouse anti-rat ED1 (Sero-
tec Ltd., Oxford, UK) was diluted at 1:50. Polyclonalby comparison to RNA molecular weight markers (Pro-
mega) using the same analysis package and confirmed rabbit anti-rat Bcl-2 (1:400; Pharmingen, San Diego, CA,
USA) was diluted at 1:400. Thereafter, the sections wereby visual comparison to the ribosomal RNA subunits.
Optical density values for Bax and Bcl-2 were corrected stained by an avidin-biotinylated horseradish-peroxidase
procedure using a commercially available kit (ABC Elite;for loading using the housekeeping gene cyclophilin [4,
8, 26]. Results were expressed as percentage of controls Vector Laboratories). Finally, the color was developed by
the 3-Amino-9-ethylcarbazole (AEC) substrate (VectormRNA densities. The Bax to Bcl-2 mRNA ratio was de-
termined for each sample individually by reprobing of Laboratories) and counter stained with hematoxylin.
Control sections were incubated with the same speciesthe same membrane and dividing the volume density for
Bax by that for Bcl-2. normal IgG or serum at the same protein concentration
as the primary antibody. The positive staining pattern of
Measurement of tissue Bax and Bcl-2 protein levels PCNA or ED1 was semiquantitatively assessed using the
same counting system with apoptosis below.Tissue levels of Bax and Bcl-2 proteins were deter-
mined by immunoprobing of Western blots [8]. Twenty
In situ end-labeling (ISEL) for the detection ofmicrograms of protein from a 20% (wt/vol) tissue ho-
apoptotic cellsmogenate was separated on a 15% (wt/vol) polyacryl-
amide denaturing gel, and then electroblotted on to Hy- In 10% neutral-buffered formalin fixed, paraffin-embed-
ded 4-m sections, fragmented DNA was labeled in situbond enhanced chemiluminescence (ECL) nitrocellulose
(Amersham Pharmacia Biotech Ltd). The membranes with digoxigenin-deoxyuridine (dUTP) by terminal de-
oxynucleotidyl transferase (TdT) using the ApopTagwere blocked by the addition of 3% (wt/vol) bovine
serum albumin (BSA) in 0.1% (vol/vol) Tween-20 Tris- peroxidase kit (Appligene Oncor, Illkirch, France) [4,
6, 20]. Briefly, after deparaffinization and hydration,buffered saline (TBS) at 4C overnight. The Western
blots were probed with a polyclonal rabbit anti-rat Bax sections were digested by 20 g/mL proteinase K for 10
minutes at 37C and endogenous peroxidase was inacti-1:2000 (P-19; Santa Cruz Biotechnology, Santa Cruz, CA,
USA) or a monoclonal mouse anti-rat Bcl-2 at 1:2000 vated by 3% (vol/vol) H2O2 in PBS. The sections were
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immersed in TdT reaction buffer, incubated with TdT Statistical analysis
and digoxigenin-dUTP for 60 minutes at 37C, then Results are expressed as mean 	 standard error of the
transferred to “stop” buffer at 37C for 30 minutes to mean (SEM). The statistical difference was assessed by
terminate the reaction. The sections were incubated with a single factor variance (ANOVA) or the Student t test.
the anti-digoxigenin-peroxidase complex at 37C for 30 Linear correlation analysis using GraphPad InStat (Graph-
minutes, developed by using the AEC substrate and Pad Software Inc., San Diego, CA, USA) and multiple
counter stained with hematoxylin. For negative or bio- linear regression analysis using SSPS (SPSS Inc., Chi-
chemically-induced positive controls, the slides were in- cago, IL, USA) were applied to determine the correla-
cubated in TdT buffer without TdT or pre-treated with tion between parameters. P  0.05 was considered to
10 g/mL of DNAse I (Sigma, Dorset, UK) in DNA be significant.
buffer. Thirty glomerular cross-sections and 25 high
power (400 magnification) fields of tubulointerstitium
RESULTSwere examined for each experimental animal. The num-
ber of ISEL staining nuclei per glomerulus, per 400 tubu- Renal function and histology studies
lar cells or per interstitial field determined the score of There was a gradual and significant increase in protein-
glomerular (Gapo), tubular (Tapo) or interstitial (Iapo) uria from days 7 to 45 (126.0 	 13.8 to 364.2 	 62.3
apoptosis, respectively. To substantiate the specificity of mg/24 h) in NTN rats (Fig. 1A). Serum creatinine was
our results, we confirmed apoptosis by light and electron significantly raised on day 15, 30 and 45 (53.0 	 3.3,
microscopic evaluation of the characteristic morphologi- 77.0 	 5.2 and 62.4 	 7.0 mol/L; Fig. 1A). Significant
cal features such as shrunken cells with condensed nuclei evidence of GS was noted from day 7 (1.77 	 0.12), with
[3, 27, 28]. detectable changes in IF (1.58 	 0.05) from day 15. GS
and IF reached 2.73 	 0.12 and 2.50 	 0.03 by day 45Double immunostaining for ISEL and Bax, ISEL and
(Fig. 1 B, C). Computer-aided point counting showedcaspase-3, Bax and Bcl-2 or Bcl-2 and PCNA
significant tubulointerstitial injury by day 7, increasing
For double immunohistochemical staining of ISEL
from a control value of 4.2 	 0.5% to 25.1 	 1.9%, P 
and Bax, ISEL and caspase-3 Bax and Bcl-2 or Bcl-2
0.05. This gradually increased rising to 35.6 	 4.4% atand PCNA, 4 m paraffin sections were dewaxed and
day 15, 54.4 	 3.9% at day 30 and 58.1 	 3.4% by dayhydrated, then processed as described above in single
45, all P  0.01). There was a high degree of correlationstaining protocols. After incubated with TdT and digoxi-
between measurements of tubulointerstitial scarring ob-genin-dUTP or primary antibody, the sections were la-
tained using an arbitrary scarring technique and com-beled with anti-digoxigenin antibody, biotinylated sec-
puter-assisted point counting (r  0.94, P  0.01). Theseondary anti-rabbit or mouse IgG. The sections were
data indicated progressive renal insufficiency as docu-blocked again and incubated with the second primary
mented in our previous study of this model [4].antibody. Alkaline phosphatase was used to label one
target and peroxidase to label the other. Alkaline phos- Expression of Bcl-2 and Bax genes
phatase was developed to a bright pink color using Fast
Northern blot analysis revealed the presence of twoRed TR/Naphthol AS-MX solution and peroxidase was
Bax mRNA transcripts (a predominant 1.0 kb speciesvisualized as yellow brown using diaminobenzidine.
and a less abundant 1.5 kb species) and the presence of
a Bcl-2 transcript of 7.5 kb (Fig. 2). In comparison toDetection of caspase-3 activity
controls (100%), the level of Bax mRNA was signifi-One hundred micrograms of protein extracted from
cantly increased at all time points in NTN kidneys (199%kidney tissues was assayed for caspase-3 activity by the
on day 45). By contrast, the expression of Bcl-2 mRNAability to cleave the fluorogenic substrate, acetyl-Asp-
was significantly decreased on day 7, 15 and 45 (62% ofGlu-Val-Asp (Ac-DEVD)-7-Amino-4-Methyl Couma-
control; Fig. 2). Subsequently, the ratio of kidney Baxrin (AMC), using the modified Fluorometric CaspACE
to Bcl-2 mRNA shifted in favor of Bax throughout theAssay System (Promega) [4]. The specificity of assay was
time course by 2.6-, 4.5-, 2.4- and 3.6-fold at days 7, 15,evaluated using caspase-3 inhibitor Ac-DEVD-aldehyde
30 and 45, respectively, compared to that of controls(CHO). The product of substrate cleavage was moni-
(Fig. 3A).tored in a fluorescence microplate reader (SOFTmax
PRO; Molecular Devices Corp., Palo Alto, CA, USA).
Tissue levels of Bax and Bcl-2 proteinsThe fluorescence intensity was calibrated with standard
Western blot analysis showed that the level of the 21concentrations of AMC, and the caspase-3 activity calcu-
kD Bax protein was significantly increased (177 andlated from the slope of recorder trace and expressed in
363% of controls) and that of the 26 kD Bcl-2 proteinpicomols per minute per g of protein (pmol AMC/min/
g prot) at 30C. was significantly decreased (21 and 17% of controls) on
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Fig. 1. Time course changes of renal function (A), fibrosis (B and C ), apoptosis (D), proliferating cell nuclear antigen (PCNA; E ) and ED1 (F )
in the kidneys of rats submitted to nephrotoxic nephritis (NTN). Data are mean 	 SEM. Statistical significance when compared to respective
controls is *P  0.05 and **P  0.01; N  6 to 8 in NTN, N  4 in controls. Abbreviations are: UP, proteinuria; SCr, serum creatinine; G, glo-
merulus; T, tubules; I, interstitium. The score of apoptosis, PCNA or ED1 is the number of in situ end-labeling (ISEL) and PCNA nuclei or
ED1 cells per glomerulus, per 400 tubular cells or per 400 interstitial field.
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Fig. 2. Tissue levels of Bax and Bcl-2 mRNA
by Northern blot analysis in NTN rat kidneys.
Sample autoradiographs from day 15 kidneys
showing transcriprts of 1.0 kb and 1.5 kb for
Bax (top), 7.5 kb for Bcl-2 (middle) and 1.8
kb transcript for cyclophilin (bottom). Abbre-
viations are: NTN, nephrotoxic nephritis; cyc,
cyclophilin. Histogram shows volume density
analysis of autoradiographs corrected for load-
ing using cyclophilin. Data are expressed as
percentage of the control value. N  4 for
controls and N  6 for NTN. Symbols are:
( ) Bax in NTN; () Control; ( ) Bcl-2 NTN;
*P  0.05, **P  0.01.
Fig. 3. Changes in the ratio of Bax to Bcl-2
at mRNA (A) and protein (B) levels in NTN
kidneys ( ) compared to that in controls ().
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ED1 cells were significantly increased in the glomeruli
throughout the time course both with a peak on day 7.
In the tubules and interstitium of NTN kidneys, PCNA
cells increased by day 15 and peaked on day 30, ED1
cells increased from day 7 and reached a maximum on
day 15, both remained high until the end of the experi-
ment (Fig. 1 E, F). PCNA nuclei or ED1 cells were
localized in the inflamed or sclerotic glomeruli, dilated
tubules and expanded interstitium (Fig. 6 G-I). No stain-
ing was observed in the sections that were incubated
with normal IgG or serum (not shown).
Level of apoptosis
A few apoptotic cells were noted in the glomeruli,
tubules and interstitium of control rats (Fig. 1D). In NTN
kidneys, glomerular apoptosis was significantly increased,
peaking on day 7 and remaining significantly elevated
Fig. 4. Western blot analysis for Bax and Bcl-2 proteins in NTN kid-
on days 15 and 30. In the tubules and interstitium ofneys. Sample immunoblots showing the 21 kD Bax protein (top) and
the 26 kD Bcl-2 protein (bottom) generated from day 7 kidney homoge- NTN kidneys, apoptosis was significantly increased from
nates. Histogram shows volume density analysis of chemiluminescent day 15 onwards, peaking on day 45 (Fig. 1D). More apo-exposed films. Symbols are: ( ) Bax%; () control; ( ) Bcl-2%. Data
ptotic cells were seen in the inflamed or sclerotic glomeruliare expressed as percentage of the control value. N  4 for control and
N  5 for NTN. *P  0.05, **P  0.01 compared with the control (Fig. 6A), dilated or atrophied tubules (Fig. 6B) and
kidneys.
expanded interstitium (Fig. 6C). In biochemical positive
control sections, nearly all cell nuclei stained, but most
of them with normal shape and no cytoplasmic condensa-
days 7 and 45 in NTN kidneys (Fig. 4). The ratio of tion (not shown). In the negative control sections no
kidney Bax to Bcl-2 protein was increased throughout staining was present (not shown). Electron microscopy
the time course by 10.1-, 3.1-, 2.9- and 45.6-fold at days confirmed apoptotic cells that had distinct morphological
7, 15, 30 and 45, respectively (Fig. 3B). motifs in the glomeruli, tubules and interstitium (Fig. 7).
Distribution of Bax, Bcl-2, PCNA and ED1 Double staining for apoptosis, PCNA, Bcl-2, Bax
In control rats, Bax immunostaining was mainly ob- and caspase-3
served in the distal tubules, however, no staining was Bax and ISEL (Fig. 5G) or caspase-3 and ISEL (Fig.
found in the proximal tubules, glomeruli or interstitium 6G-I) double staining positive cells were found in dam-
(Fig. 5A). After the induction of NTN, obvious Bax aged tubules inflamed glomeruli and interstitium. A
staining was present in the damaged glomerular cells number of cells including some tubular cells stained posi-
(Fig. 5B) by day 7 and increased in the tubules, particu- tively for both Bax and Bcl-2 (Fig. 5H). PCNA and Bcl-2
larly so in dilated proximal tubules (Fig. 5C). Bax stain-
double-stained positive cells also were found in some
ing also was visible in interstitial cells (Fig. 5C) and the
tubules (Fig. 5I).
cells shed into tubular lumen (Fig. 5D).
The profile of Bcl-2 protein distribution was different Caspase-3 activity
from Bax and it appeared to be less abundant. There
In NTN rat kidneys, caspase-3 activity was significantlywas almost no detectable Bcl-2 immunostaining in the
increased at all time points compared with their controls.tubules, glomeruli and interstitium of normal rat kidneys
On day 7, this increase was 0.107 	 0.006 (vs. 0.051 	(Fig. 5E). By contrast, Bcl-2 staining was increased in
0.003) pmol AMC/min/g prot, dropped to 0.085	 0.003some areas of NTN kidneys, which was mainly confined
(vs. 0.046 	 0.009) pmol AMC/min/g prot on day 15,to atrophic tubules (Fig. 5F). The pattern of Bcl-2 immu-
rising again to 0.106 	 0.005 (vs. 0.046 	 0.008) pmolnostaining was consistent between the two antibodies
AMC/min/g prot on day 30 and reaching a peak 0.114	used, however, the polyclonal rabbit anti-rat Bcl-2 anti-
0.006 (vs. 0.048 	 0.008) pmol AMC/min/g prot on daybody gave the most intense staining.
45. Ac-DEVD-CHO, a specific and competitive tetra-A small number of PCNA or ED1 cells were noted
peptide inhibitor of caspase-3, almost fully abolished thein the glomeruli, tubules and interstitium of control rat
kidneys (Fig. 1 E, F). In the NTN kidneys, PCNA or caspase-3 activity demonstrating the specificity of assay.
Fig. 5. Distribution of Bax and Bcl-2 in control and NTN kidneys. Bax immunostaining was visible in the distal tubules and cortical collecting
ducts of control kidneys (200, A) and in the glomeruli (200, B and C ), dilated proximal tubules and interstitial cells of NTN kidneys (100,
C ). Some cells stained for Bax had sloughed into the tubular lumen (400, D). There was no Bcl-2 immunostaining in the control kidneys (200,
E ) but was present in the atrophied tubules of NTN kidneys (100, F ). In the NTN kidneys, double staining of Bax (bright pink) and ISEL
(brown) was noted in the atrophied tubules (200, G). Double staining of Bcl-2 (brown) and Bax (bright pink) was also found in atrophied and
dilated tubules (400, H) as well as Bcl-2 (bright pink) and PCNA (brown) double staining in the atrophied tubules (400, I ). The dark pink
and brown pattern indicates composite staining.
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Fig. 6. Renal cell apoptosis, proliferation and inflammation. The determination of apoptotic cells using ISEL at 400 magnification in glomerulus
(A), tubule (B) and interstitium (C ) of NTN kidneys. PCNA staining nuclei at 200 magnification in inflamed glomerulus (D), dilated tubules
(E ) and expended interstitium (E ) of NTN kidneys. ED1 positive cells at 100 magnification in glomeruli and interstitium (F ). Double staining
for caspase-3 (pink) and ISEL (brown) in the tubule (G, I ) and interstitium (H, I) in NTN kidneys.
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Fig. 7. Apoptotic cells (indicated by arrows)
in the glomerulus (A, 14337), tubules (B,
11124) and interstitium (C,11124) of NTN
kidney by electron microscopy.
Correlations between Bax, Bcl-2, caspase-3 activity, up-regulation of caspase-3 at activity, protein and
mRNA levels positively correlated with apoptosis as wellapoptosis, proliferation, inflammation, fibrosis and
renal function as inflammation, proliferation and subsequent glomeru-
losclerosis, tubular atrophy and interstitial fibrosis in thisThere was parallel expression of protein and mRNA
model [4]. In our current study using the same model,for Bax or Bcl-2 (r  0.355 and 807, P  0.01). The
we have looked upstream of caspase-3 and observed anmRNA and protein level of Bax positively correlated
increase in Bax transcription, translation and distribu-with the caspase-3 activity (r  0.695 and 0.464) and
tion, and a decrease of total Bcl-2 mRNA and proteinoverall apoptosis (r  0.879 and 0.444), while that of
in NTN kidneys, despite local Bcl-2 protein increases inBcl-2 negatively correlated with these two parameters
some atrophic tubules. The ratio of Bax to Bcl-2 at both(r0.520 and0.686 for caspase-3 activity, r0.431
the mRNA and protein levels in the NTN kidneys wasand 0.482 for apoptosis; all P  0.01). Among Bax and
significantly increased through the time course, andBcl-2 protein and mRNA, multiple regression analysis
closely correlated with caspase-3 activity, apoptosis, in-showed that Bcl-2 protein was the best match of cas-
flammation and renal fibrosis. This indicates the poten-pase-3 activity (Std 
 coefficient  0.549, P  0.01).
tial importance of the Bax/Bcl-2 ratio and its probableOverall, apoptosis correlated with inflammation (r 
effect on caspase-3 in mediating apoptosis associated0.507), proliferation (r 0.604), fibrosis (r 0.930), Uprot
with inflammation and renal cell deletion in the process(r  0.887) and SCr (r  0.753), all P  0.01. There was
of renal fibrosis.no correlation between the expression of Bcl-2 mRNA/
Apoptosis eliminates cells in response to a varietyprotein and proliferation. The ratios of Bax to Bcl-2
of stimuli and provides protection against cancer andmRNA and protein correlated with caspase-3 activity
inflammation as well as maintenance of homeostasis in(r  0.742 and 0.531, P  0.01), overall apoptosis (r 
living organisms [30]. Tissue remodeling after injury is0.712 and 0.540, P  0.01; Fig. 8), proliferation (r 
dependent on the balance between cellular apoptosis0.611, P  0.01 mRNA only), inflammation (r  0.474,
and proliferation. Although the efficient deletion by apo-P  0.01 and r  0.419, P  0.05) and overall fibrosis
ptosis of excessive, damaged or non-functioning renal(r  0.474 and 0.729, P  0.01). There were also signifi-
cells and infiltrating inflammatory cells is beneficialcant (P  0.01) correlations with GS (r  0.723 and
[2, 31], but the loss of renal parenchymal cells by uncon-0.456), TA (r  0.684 and 0.463) and IF (r  0.69
trolled apoptosis is detrimental as it induces a reductionand 0.46) when analyzed separately. Furthermore, the
of functional mass leading to renal insufficiency [3, 4,ratio of Bax/Bcl-2 mRNA and protein was better corre-
32]. This NTN model is characterized by an early severelated with tubular apoptosis (both Std 
 coefficient 
glomerulonephritis followed by progressive glomerulo-1.002, P  0.01) rather than interstitial or glomerular
sclerosis, tubular atrophy and interstitial fibrosis [33, 34].apoptosis by multiple regression analysis.
The reduction of glomerular hypercellularity, the resolu-
tion of inflammation and proliferation, and the progres-
DISCUSSION sion of cellular crescents to fibrous crescents previously
have been associated with apoptosis in this and similarThe role of Bax and Bcl-2 in the process of apoptosis
has been widely investigated in numerous in vitro and models [3, 4]. However, research relating to the control
and regulation of apoptosis in this situation has beenin vivo systems [14, 29]. However, there are only limited
data regarding the ratio of Bax to Bcl-2 and its regulation limited to date. This is surprising given that control of
such systems is likely to be of therapeutic value. Here,of cellular apoptosis in immune-mediated glomerulone-
phritis and renal fibrosis. Previously, we found that the we have begun to address this issue by describing the
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Fig. 8. Correlation between the overall renal
apoptosis score and the ratio of Bax and Bcl-2
at the mRNA and protein in the kidneys of
NTN rats. Symbols are: () Bax/Bcl-2; ()
Bax/Bcl-2; (solid line) linear Bax/Bcl-2; (dashed
line) linear Bax/Bcl-2
involvement of Bax/Bcl-2 and caspase-3 in the disease Bcl-2, which is consistent with our previous studies on
SNx rats and those of others in mice [8, 38, 39]. In normalprocess.
Bcl-2-related proteins constitute the most relevant kidneys, immunohistochemistry shows no or very faint
staining of Bcl-2, although Northern and Western blotclass of apoptosis regulatory gene products [35]. More
important than the level of expression of individual anti- analyses showed abundant levels of both mRNA and
protein. This difference between cortical and cellularor pro-apoptotic proteins is the relative proportion of
death antagonists to agonists, and this ratio determines measurements may be attributed to the different sensitiv-
ity of detection techniques as previously outlined [8],how a cell will respond to an apoptotic signal [35]. Bcl-2
is the best-understood gene in a cell death pathway, whereby an immunoblot is in general more sensitive than
immunostaining. This is simply a consequence of theinhibiting apoptosis and extending cell survival [36]. Bax
has extensive homology with Bcl-2, which homodimer- fact that on a Western blot, protein from many cells is
concentrated into a single band, but immunohistochem-izes or heterodimerizes with Bcl-2 in vivo. Bax in itself
does not cause cell death, but its elevated expression istry is dependent on the protein in a single cell obtaining
a detection threshold. Consequently, Western blottingfavors an entry into the apoptotic program following a
death signal by countering Bcl-2 activity. Simply, the can detect a low expression in many cells whereas immu-
nohistochemistry is suited to high expression in a fewratio of Bax to Bcl-2 determines the susceptibility of a
cell to death following an apoptotic stimulus [13]. cells. However, a small number of cells (mainly within
atrophic tubules) up-regulated Bcl-2, which seems con-Our current study found that both Bax transcription
and translation levels were significantly increased during tradictory to its apoptotic regulatory function and its
tissue mRNA and protein expression. Although this hasthe progression of renal scarring in the NTN model. This
Bax protein was localized by immunohistochemistry to been addressed in a previous SNx model [8], it is worth
reiterating that the increased immunostainable Bcl-2 indilated tubules, damaged glomeruli and interstitial cells
of NTN kidneys. The early peak in glomerular apoptosis damaged tubules may be a protective mechanism that
prevents further cell loss by apoptosis [40]. The localiza-is likely to result from the clearance of inflammatory
cells, while the late peak of apoptosis appears to be tion of both Bax and Bcl-2 in the same cells, as noted by
double staining, may indicate two opposing mechanismslinked to the deletion of renal parenchymal cells that
coincides with the severe GS, TA as well as interstitial trying to determine the fate of cells. In addition, the co-
localization of Bcl-2 with PCNA in regenerating tubularinjury and fibrosis. A low expression of Bax protein in
the distal tubules, cortical collecting ducts and medullary cells within atrophic tubules may be of particular impor-
tance in counteracting tubular atrophy.loops of Henle was detected in the kidneys of control
rats, which is in line with previous reports [8, 37]. The In a similar protective role, the maximal Bcl-2 protein
expression in glomerular cells occurring 24 hours fol-distribution of Bax was more widespread than that of
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lowing the induction of NTN in Wistar rats has been of cytochrome c and promoting further caspase activa-
tion as part of a positive feedback loop to ensure theassociated with inappropriate cell survival leading to glo-
merular hypercellularity and exacerbation of glomerulo- occurrence of apoptosis [48]. Our current study shows
that both increased caspase-3 activity and apoptosis coin-nephritis [41]. In human crescentic glomerulonephritis,
apparent Bcl-2 expression in the parietal glomerular epi- cide with decreased of Bcl-2 protein, which provides
circumstantial evidence that caspase-3 may be the prote-thelial cells may be associated with the development of
cellular crescent [42]. Up-regulated Bcl-2 mRNA and ase that is responsible for the cleavage of Bcl-2 and
occurrence of apoptosis in vivo. It is important to noteprotein also was noted in other several types of human
proliferative glomerulonephritis [43]. However, in this that the infiltration of ED1 positive cells paralleled the
increase of apoptosis in glomeruli, tubules and intersti-Wistar Kyoto rat NTN model, there is almost no Bcl-2
staining in glomeruli. Furthermore, there is no positive tium. The inflammatory microenvironment may favor
elevated apoptosis of renal parenchymal cells by releas-correlation between Bcl-2 mRNA/protein and PCNA
staining, which implies that Bcl-2 prolongs cell survival ing an array of inflammatory mediators such as trans-
forming growth factor-
 (TGF-
) [49], TNF- [50], nitricthrough blocking cell apoptosis, rather promoting cell
proliferation [10]. oxide (NO) [51] or oxygen free radicals [52]. These in-
flammatory mediators are well known apoptotic inducersDue to the interplay between members of the Bcl-2
family, perhaps the most important observation is the acting through the regulation of Bcl-2 family members.
The application of monoclonal antibodies to TGF-
 haschanges in the ratio of Bax to Bcl-2. At both the mRNA
and protein levels there is a strong increase in this ratio been shown to ameliorate tubular apoptosis in unilateral
ureteral obstruction (UUO) rats through neutralizingthat favors apoptosis in NTN rats. Interestingly, while
at the mRNA level this increase is progressive from day higher TGF-
 and up-regulating Bcl-2 [49].
To conclude, the Bax/Bcl-2 ratio acting through cas-7 to 15, reduced at day 30, and recovering at day 45, at
the protein level, there are distinct early and late peaks pase-3 may control renal cell apoptosis associated with
the progressive glomerulosclerosis, tubular atrophy andthat coincide with the early glomerular apoptosis and
the late progressive tubular atrophy. The differences in- interstitial fibrosis in immune-mediated experimental
glomerulonephritis and renal scarring. The developmentdicate further translational or post-translational control
of these proteins within the diseased kidney. of pharmaceuticals directed toward the Bcl-2 family
More recently, a class of cysteine proteases termed members, to regulate the Bax/Bcl-2 ratio, may have ther-
the caspase family has emerged as central player in the apeutic value via the modulation of apoptosis in pre-
process of apoptosis [13]. Of this family, caspase-3 is venting the progressive cellular depletion associated with
the best functionally linked enzyme with apoptosis, an renal fibrosis and chronic renal insufficiency.
apoptotic executor that is downstream of the Bcl-2 fam-
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